Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of infectious diseases
3.2.1.2 Increasing outsourcing of sterility testing services
3.2.1.3 Stringent regulatory requirements for pharmaceutical companies
3.2.2 Industry pitfalls & challenges
3.2.2.1 Complexity of testing procedures
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Kits & reagents
5.3 Services
5.4 Instruments
Chapter 6 Market Estimates and Forecast, By Test, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Membrane filtration
6.3 Direct inoculation
6.4 Rapid microbial method
6.4.1 ATP bioluminescence
6.4.2 Fluorescent -based
6.4.3 Solid-phase cytometry
6.4.4 Other rapid microbial methods
6.5 Other tests
Chapter 7 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 In-house testing
7.3 Outsourced testing
Chapter 8 Market Estimates and Forecast, By Sample, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Sterile drugs
8.3 Biologics and therapeutics
Chapter 9 Market Estimates and Forecast, By End-user, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Pharmaceutical & biotechnology companies
9.3 CROs and contract testing laboratories
9.4 Compounding pharmacies
9.5 Other end-users
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Alcami Corporation
11.2 bioMerieux SA
11.3 BA Sciences
11.4 Charles River Laboratories
11.5 Nelson Laboratories, LLC
11.6 Merck KGaA
11.7 Pacific BioLabs Inc.
11.8 Rapid Micro Biosystems Inc.
11.9 SGS Societe Generale de Surveillance SA.
11.10 STERIS Corporation
11.11 Thermo Fisher Scientific Inc.
